Children with FASD show high prevalence of developing epilepsy

NewsGuard 100/100 Score

Children with Fetal Alcohol Spectrum Disorder (FASD) show a very high prevalence of developing epilepsy and having seizures, according to a national study by Queen's University researchers.

Six per cent of study participants had epilepsy and 12 percent had one or more seizures in their lifetimes. By comparison, less than one percent of the general population is expected to develop epilepsy. The study results also showed that individuals were more likely to have epilepsy, or a history of seizures, if exposure to alcohol had occurred in the first trimester or throughout the entire pregnancy.

"There are very few studies that have examined the relationship between seizures and epilepsy among individuals with FASD," says study co-author James Reynolds, a pharmacology, toxicology and neuroscience researcher at Queen's University. "The consensus recommendation of scientists, clinicians, and public health officials around the world is very clear-a woman should abstain from drinking during pregnancy as part of an overall program of good prenatal health care that includes good nutrition, adequate exercise, and sufficient rest."

Researchers examined the histories of 425 individuals between the ages of two and 49 years from two FASD clinics. They compared risk factors such as the level of exposure to alcohol or other drugs, type of birth, and trauma with the co-occurrence of epilepsy or a history of seizures in participants with confirmed FASD diagnoses. The report builds on a growing body of evidence that maternal drinking during pregnancy may put a child at greater risk for an even wider variety of neurologic and behavioral health problems than thought before.

The study results will appear in the June issue of Alcoholism: Clinical & Experimental Research. The research team included St. Michael's Hospital, University of Alberta, University of Toronto, and the Toronto Western Research Institute.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers find new clues to understanding the progression of primary membranous nephropathy